Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1200

1.

Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.

Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.

Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1124-9. doi: 10.1016/j.ijrobp.2007.11.044.

PMID:
18313526
[PubMed - indexed for MEDLINE]
2.

Long term tolerance of high dose three-dimensional conformal radiotherapy in patients with localized prostate carcinoma.

Zelefsky MJ, Cowen D, Fuks Z, Shike M, Burman C, Jackson A, Venkatramen ES, Leibel SA.

Cancer. 1999 Jun 1;85(11):2460-8.

PMID:
10357419
[PubMed - indexed for MEDLINE]
3.

Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy.

Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z.

Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):765-71.

PMID:
15913914
[PubMed - indexed for MEDLINE]
4.

Preliminary report of toxicity following 3D radiation therapy for prostate cancer on 3DOG/RTOG 9406.

Michalski JM, Purdy JA, Winter K, Roach M 3rd, Vijayakumar S, Sandler HM, Markoe AM, Ritter MA, Russell KJ, Sailer S, Harms WB, Perez CA, Wilder RB, Hanks GE, Cox JD.

Int J Radiat Oncol Biol Phys. 2000 Jan 15;46(2):391-402.

PMID:
10661346
[PubMed - indexed for MEDLINE]
5.

[Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer].

Aillères N, Azria D, Thézenas S, Barbier N, Fenoglietto P, Delard R, Hay MH, Dubois JB.

Cancer Radiother. 2004 Apr;8(2):59-69. English, French.

PMID:
15063872
[PubMed - indexed for MEDLINE]
6.

Role of intensity-modulated radiotherapy in reducing toxicity in dose escalation for localized prostate cancer.

Al-Mamgani A, Heemsbergen WD, Peeters ST, Lebesque JV.

Int J Radiat Oncol Biol Phys. 2009 Mar 1;73(3):685-91. doi: 10.1016/j.ijrobp.2008.04.063. Epub 2008 Aug 19.

PMID:
18718725
[PubMed - indexed for MEDLINE]
7.

Dose escalation in prostate radiotherapy up to 82 Gy using simultaneous integrated boost: direct comparison of acute and late toxicity with 3D-CRT 74 Gy and IMRT 78 Gy.

Dolezel M, Odrazka K, Vaculikova M, Vanasek J, Sefrova J, Paluska P, Zouhar M, Jansa J, Macingova Z, Jarosova L, Brodak M, Moravek P, Hartmann I.

Strahlenther Onkol. 2010 Apr;186(4):197-202. doi: 10.1007/s00066-010-2065-x. Epub 2010 Mar 26.

PMID:
20354663
[PubMed - indexed for MEDLINE]
8.

Improved toxicity profile following high-dose postprostatectomy salvage radiation therapy with intensity-modulated radiation therapy.

Goenka A, Magsanoc JM, Pei X, Schechter M, Kollmeier M, Cox B, Scardino PT, Eastham JA, Zelefsky MJ.

Eur Urol. 2011 Dec;60(6):1142-8. doi: 10.1016/j.eururo.2011.08.006. Epub 2011 Aug 12.

PMID:
21855208
[PubMed - indexed for MEDLINE]
9.

Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.

Pederson AW, Fricano J, Correa D, Pelizzari CA, Liauw SL.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):235-41. doi: 10.1016/j.ijrobp.2010.09.058. Epub 2010 Dec 14.

PMID:
21163587
[PubMed - indexed for MEDLINE]
10.

Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.

Deville C, Both S, Hwang WT, Tochner Z, Vapiwala N.

Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):763-72. doi: 10.1016/j.ijrobp.2009.08.043. Epub 2010 Feb 18.

PMID:
20171807
[PubMed - indexed for MEDLINE]
11.

Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent iodine-125 implantation for early-stage prostatic cancer.

Zelefsky MJ, Wallner KE, Ling CC, Raben A, Hollister T, Wolfe T, Grann A, Gaudin P, Fuks Z, Leibel SA.

J Clin Oncol. 1999 Feb;17(2):517-22.

PMID:
10080594
[PubMed - indexed for MEDLINE]
12.

Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancer.

Zelefsky MJ, Kelly WK, Scher HI, Lee H, Smart T, Metz E, Schwartz L, Fuks Z, Leibel SA.

J Clin Oncol. 2000 May;18(9):1936-41.

PMID:
10784635
[PubMed - indexed for MEDLINE]
13.

Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapy.

Zelefsky MJ, Nedelka MA, Arican ZL, Yamada Y, Cohen GN, Shippy AM, Park JJ, Zaider M.

Brachytherapy. 2008 Jan-Mar;7(1):1-6. doi: 10.1016/j.brachy.2007.12.002.

PMID:
18299108
[PubMed - indexed for MEDLINE]
14.

Long-term urinary toxicity after 3-dimensional conformal radiotherapy for prostate cancer in patients with prior history of transurethral resection.

Sandhu AS, Zelefsky MJ, Lee HJ, Lombardi D, Fuks Z, Leibel SA.

Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):643-7.

PMID:
11020559
[PubMed - indexed for MEDLINE]
15.

Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer.

Mohammed N, Kestin L, Ghilezan M, Krauss D, Vicini F, Brabbins D, Gustafson G, Ye H, Martinez A.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):204-12. doi: 10.1016/j.ijrobp.2010.10.009. Epub 2010 Dec 16.

PMID:
21167653
[PubMed - indexed for MEDLINE]
16.

Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy.

Peeters ST, Heemsbergen WD, van Putten WL, Slot A, Tabak H, Mens JW, Lebesque JV, Koper PC.

Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34.

PMID:
15752881
[PubMed - indexed for MEDLINE]
17.

Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.

Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.

Cancer. 2009 Dec 1;115(23):5596-606. doi: 10.1002/cncr.24558.

PMID:
19670452
[PubMed - indexed for MEDLINE]
Free Article
18.

Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 prostate cancer trial.

Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM, Bahary JP, Morton GC, Parliament MB, Sandler HM.

Int J Radiat Oncol Biol Phys. 2013 Dec 1;87(5):932-8. doi: 10.1016/j.ijrobp.2013.07.041. Epub 2013 Oct 8.

PMID:
24113055
[PubMed - indexed for MEDLINE]
19.

Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer.

Shu HK, Lee TT, Vigneauly E, Xia P, Pickett B, Phillips TL, Roach M.

Urology. 2001 Jan;57(1):102-7.

PMID:
11164152
[PubMed - indexed for MEDLINE]
20.

High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.

Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.

J Urol. 2001 Sep;166(3):876-81. Erratum in: J Urol 2001 Nov;166(5):1839.

PMID:
11490237
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk